CIDRAP newsletters options
Two more Ebola infections and two more deaths from the virus have been reported from the Democratic Republic of the Congo (DRC) Equateur province outbreak, the World Health Organization (WHO) African regional office said on Twitter today.
In a comparative analysis published late last week in Clinical Infectious Diseases, the antiviral drug remdesivir was linked to significantly greater recovery and a 62% lower death rate by day 14 versus standard treatment in hospitalized adults with severe COVID-19.
"We need to reopen the schools with the understanding the virus is still here," CDC Director Robert Redfield says.
In India, surging COVID-19 has led to remdesivir shortages, and the outbreak is expanding in Brazil.
A plague outbreak in the Democratic Republic of the Congo (DRC) that began on June likely involves all three types, including pneumonic, and has so far resulted in 45 cases, 9 of them fatal, the World Health Organization (WHO) said yesterday in a statement.
A study yesterday in The Lancet Child & Adolescent Health found no evidence of COVID-19 transmission between 120 babies born to mothers with COVID-19, even after 2 weeks of breastfeeding with appropriate hygiene precautions.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Scientists in Luxembourg this week announced the creation of a new biobank that will collect and analyze strains of bacteria from Europe that are resistant to last-resort antibiotics.
About 47% of US adults have an underlying condition strongly tied to severe COVID-19 illness.
WHO head reiterates that political leadership and community engagement are the 2 key response pillars.
July continues to look like April for the US, just as pro baseball opens.
A 2019 survey of clinical commissioning groups in England showed an increase in antimicrobial stewardship (AMS) programs compared with the previous survey, according to a report yesterday from UK nonprofit The Patients Association.
A randomized controlled trial of hospitalized COVID-19 patients in Brazil found that the use of hydroxychloroquine, with or without azithromycin, did not improve clinical status at 15 days compared with standard care, researchers reported today in the New England Journal of Medicine.
Antibody levels dropped by about half every 73 days—not good news for vaccine prospects.
For the first time in more than a month, daily US deaths top 1,000.
Dr. Osterholm clarifies that he supports the wearing of cloth face coverings in public and urges people to stop citing CIDRAP and him as grounds for not wearing masks, but he also asks that advocates not use poorly conducted studies to support their use.
In the past day, the US, Brazil, and India reported more than 143,000 new cases combined.
Early in the COVID-19 pandemic, US emergency department (ED) physicians said they were stressed by exposures to infected patients to the point that it impinged on their home lives and female ED doctors reported higher stress levels than their male counterparts, according to survey results published today in Academic Emergency Medicine.
Two more Ebola infections were confirmed in the Democratic Republic of the Congo (DRC) Equateur province outbreak, both of them in Mbandaka, the provincial capital, the World Health Organization (WHO) African regional office and its DRC office said on Twitter.
Health officials see no let-up in the surge of COVID-19 cases in the Americas.
Data show that at least 10 times more people were probably infected than previously reported.
